SARS News and Research

RSS

Research shows fitness suffered in most individuals during COVID-19

Researchers from the University of Texas, San Antonio and UT-Health Sciences, Texas, recently attempted to fill this knowledge gap by addressing how the COVID-19 pandemic and related stay-at-home orders are changing the daily habits of individuals.

14 Dec 2020

Recommendations to prevent SARS-CoV-2 spread via aerosols in hospitals and nursing homes

A variety of measures are necessary to prevent the spread of the coronavirus SARS-CoV-2 in hospitals and nursing homes. It is particularly important to develop an appropriate strategy to protect healthcare workers from airborne transmission.

14 Dec 2020

Quality family time and work flexibility: Australians report unexpected positives to the COVID-19 pandemic

Researchers at the University of Sydney wanted to determine what Australians think are the positive effects brought on by the pandemic.

14 Dec 2020

Researchers in Canada explore risks of SARS-CoV-2 transmission in retirement homes

Researchers at the McMaster University, Canada, have found that the higher the population in retirement homes, the higher the risk of COVID-19 outbreaks. Moreover, they found that retirement homes in a community with a higher ethnic concentration are also more likely to face COVID-19 outbreaks.

14 Dec 2020

UK researchers examine university students behavior amid COVID-19 prevention measures

A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.

14 Dec 2020

Remdesivir likely to be highly effective treatment for COVID-19

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

The focus is increasingly moving towards vaccine roll-out as the world faces the real possibility of the second year of social and economic restrictions.

14 Dec 2020

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

A new study suggests an impact of the COVID-19 vaccine on SARS-CoV-2 attack rate, and hospitalizations, even with no protection against infection.

14 Dec 2020

Less sensitive rapid tests may miss asymptomatic/presymptomatic SARS-CoV-2 infection

The rapid transmissibility of SARS-CoV-2 has posed a significant challenge to COVID-19 containment measures.

14 Dec 2020

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Researchers in the United States and Australia have conducted a comprehensive analysis of the epitope recognition patterns associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans.

14 Dec 2020

60-second breath test to detect COVID-19 with IONICON PTR-TOFMS

Singapore start-up develops fast breath test based on PTR-TOF technology.

From Ionicon Analytik Ges.m.b.H. 14 Dec 2020

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Scientists have suggested that a proportion of the population have pre-existing immunity to COVID-19 because of T cells primed against SARS-CoV-2 antigens.

14 Dec 2020

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

In the current COVID-19 pandemic, SARS-CoV-2 has led to millions of infections worldwide, with over 1.5 million deaths.

14 Dec 2020

Recovered COVID-19 patients exhibit persistent cellular immunity

Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.

14 Dec 2020

SARS-CoV-2 Nsp3 protease activity and nanobody inhibitor development

A new study published in the pre-print server bioRxiv* explores the viral enzyme PLpro, encoded in the nonstructural protein nsp3, and its inhibitors. T

14 Dec 2020

RNA editing within host linked to SARS-CoV-2 variants

Since the start of the COVID-19 pandemic, the causative virus, SARS-CoV-2, has undergone several mutations.

14 Dec 2020

Households are a high-risk setting for SARS-CoV-2 transmission

The results of a new study have confirmed that households, and other crowded indoor environments, are high-risk settings for SARS-CoV-2 transmission.

14 Dec 2020

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts.

14 Dec 2020

Digital chest drainage systems could help reduce COVID-19 spread, research shows

Pioneering research, which reveals digital chest drains generate and distribute less aerosol generated particles compared to traditional water seal systems, has been published in the Seminars in Thoracic and Cardiovascular Surgery journal.

14 Dec 2020

SARS News and Research

Research shows fitness suffered in most individuals during COVID-19

Recommendations to prevent SARS-CoV-2 spread via aerosols in hospitals and nursing homes

Quality family time and work flexibility: Australians report unexpected positives to the COVID-19 pandemic

Researchers in Canada explore risks of SARS-CoV-2 transmission in retirement homes

UK researchers examine university students behavior amid COVID-19 prevention measures

Remdesivir likely to be highly effective treatment for COVID-19

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

Less sensitive rapid tests may miss asymptomatic/presymptomatic SARS-CoV-2 infection

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

60-second breath test to detect COVID-19 with IONICON PTR-TOFMS

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

Recovered COVID-19 patients exhibit persistent cellular immunity

SARS-CoV-2 Nsp3 protease activity and nanobody inhibitor development

RNA editing within host linked to SARS-CoV-2 variants

Households are a high-risk setting for SARS-CoV-2 transmission

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Digital chest drainage systems could help reduce COVID-19 spread, research shows

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News